Impax Loses Fees Bid In Opioid Pay-For-Delay Row With FTC
A Pennsylvania federal judge on Monday declined to grant fees to Impax Laboratories Inc. after the Federal Trade Commission voluntarily dismissed its pay-for-delay suit over generic versions of an opioid, but...To view the full article, register now.
Already a subscriber? Click here to view full article